EUCTR2019-004121-25-DK进行中（未招募）1 期
A single-blinded multicenter randomized study comparing intubating conditions after either rocuronium 0.6 mg/kg or remifentanil 2 µg/kg in elderly patients.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Age = 80
- •- Scheduled for elective operations (expected duration of anesthesia >
- •1 hour) under general anesthesia with intubation
- •- American Society of Anesthesiologists physical status classification
- •(ASA) I to III
- •- Informed consent (see appendix 1)
- •- Read and understand Danish
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 74
排除标准
- •- Neuromuscular disease
- •- Known allergy to rocuronium, remifentanil or sugammadex
研究者
相似试验
进行中（未招募）
1 期
A randomized study comparing two types of muscle relaxants regarding the influence on tracheal intubation during anaesthesia in elderly patients (= 80 years old)The aim of this study is to determine the proportion of excellent tracheal intubation conditions at 60 seconds after administration of either rocuronium 1.0 mg/kg or suxamethonium 1 mg/kg in patients with age = 80 years.MedDRA version: 23.1Level: LLTClassification code 10051079Term: Orthopedic procedureSystem Organ Class: 100000004865MedDRA version: 20.0Level: LLTClassification code 10000082Term: Abdominal pain generalisedSystem Organ Class: 100000004856EUCTR2020-005384-31-DKRigshospitalet90
已完成
3 期
A Multi-Center, Single-Blind, Randomized Study Comparing Thymectomy to No Thymectomy in Non-Thymomatous Myasthenia Gravis (MG) Patients Receiving Prednisonemyasthenia gravismyasthenia1000381610028302NL-OMON30649ational Institute of Health5
未知
3 期
K-103-PA Phase 3 studyJPRN-jRCT2080221217Kowa Co., Ltd.340
进行中（未招募）
不适用
A multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan respectively Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 (ASTRID – Antihypertensive treatment of Systolic/diastolic hypertension comparing Teveten and Ramipril in type 2 Diabetics). - ASTRIDEUCTR2004-000703-18-ESSOLVAY PHARMACEUTICALS GMBH440
进行中（未招募）
不适用
A multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan respectively Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2. ASTRID Antihypertensive treatment of Systolic/diastolic hypertension comparing Teveten and Ramipril in type 2 Diabetics .essential hypertensionMedDRA version: 6.1Level: PTClassification code 10015488EUCTR2004-000703-18-ITSOLVAY PHARMA440